2m 2m 2m 2m 2m 2m 2m
REGENXBIO (RGNX)
NASDAQ
$10.12+$0.17 (+1.66%)
Price as of Jun 23, 2026 7:59 PM EDT- $468.9MMarket Cap
- 16.24%1-Year Change
- BiotechnologyIndustry
REGENXBIO (RGNX)
$10.12+$0.17 (+1.66%)
RGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.95 | ||
Change | +$0.88 (+9.70%) | ||
Open | $8.94 | ||
High | $10.34 | ||
Low | $8.94 | ||
Previous Close | $9.07 | ||
Volume | 2,968,623 | ||
30-Day Average Volume | 2,089,433 | ||
1-Week Change | 43.58% | ||
1-Month Change | 56.69% | ||
1-Year Change | 16.24% | ||
3-Year Change | -47.35% | ||
5-Year Change | -74.17% | ||
Fundamentals | |||
Shares Outstanding | 51.7M | ||
Total Assets | $341.9M | ||
Market Cap | $468.9M | ||
Enterprise Value | $453.7M | ||
Period: QTR TTM FY | |||
Revenue | $5.1M | ||
Net Income | -$90.1M | ||
Free Cash Flow | -$77.4M | ||
EBIT | $102.4M | ||
EBITDA | $106.3M | ||
Net Working Capital | $115.4M | ||
EPS | -$1.72 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | 89 | ||
P/B | 22 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue